The global mouth ulcers treatment market was estimated at more than US$ 1,654.00 million in 2020. The market is likely to register a CAGR of 3.7% during the forecast period from 2021 to 2027.

Mouth ulcers are painful yellow lesions with a crimson ring covering. They occur in the form of burning breaks, sores, or lesions in the soft tissues of the oral cavity like cheeks, tongue, gums, floor, lips, roof, and esophagus.

Factors affecting

The market for mouth ulcers treatment is expected to observe a significant lift in growth, owing to the increasing pervasiveness of mouth ulcers.

The main cause of mouth ulcers is tobacco consumption and smoking cessation. The rise in tobacco consumption and smoking would boost the need for ulcer treatment. Hence, it will promote the growth of the global mouth ulcers treatment market.

Moreover, the growing use of chemical-based toothpaste would lead the overall market growth. Citric foods like lemons, oranges, pineapples, tomatoes, apples, figs, and strawberries enhance the odds of mouth ulcers. Therefore, increasing the consumption of such vegetables and fruits would ultimately grow the need for treatment.

Oral hygiene is an essential practice to keep the mouth clean and disease-free. There is an enormous demand for oral and dental hygiene, owing to the rise in self-consciousness among people. The increase in awareness for oral hygiene will eventually grow the market during the forecast period.

Viral, bacterial, and fungal infections also prompt the occurrence of mouth ulcers. Apart from that, small injuries and nutritional deficiencies also lead the mouth ulcers and infections. Thus, these factors are expected to prompt market growth.

Furthermore, government initiatives to promote oral hygiene are expected to show promising growth of the mouth ulcers treatment market.

The growing geriatric population is likely to raise chances for the occurrence of mouth ulcers or sores. The increasing oral concerns due to nutritional deficiency in older people will propel the growth of the global mouth ulcers treatment market.

Advanced pharmaceutical-based ulcer treatment drugs like antimicrobial, analgesics, mouthwash, antihistamine, pain relief gels, anesthetic, sprays, lozenges, and ointments are accelerating opportunities for the growth of the global mouth ulcers treatment market.

Regional Analysis

North America held the majority of share in the global mouth ulcers treatment market in 2020. The region is anticipated to maintain dominance in the forecast period, owing to the pervasiveness in mouth ulcers, key players, advancements in drugs, and growing government initiatives for oral health in the region. Apart from that, Asia-Pacific is likely to observe the highest CAGR during the analysis period. The growing population and incline in self-medication trend in the region would grow the share of the region in the upcoming years.

COVID-19 Impact

The COVID-19 outbreak is anticipated to create promising growth in the global mouth ulcers treatment market.

COVID-19 infection suppresses the immune system by causing nutritional deficiency in the body. Vitamins and minerals deficiency can give rise to mouth ulcers. Hence, it boosted the overall growth of the global mouth ulcers treatment market.

Key Market Segments

By Drug Class

Analgesics and Corticosteroids
Antihistamine
Antimicrobial
Anesthetic
By Formulation Type

Sprays
Mouthwash
Gels
Lozenges
By Indication

Aphthous Stomatitis
Oral Lichen Planus
Others
By Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America
Key Market Players

Blistex Inc.
Bristol-Myers Squibb Company
Church & Dwight Co, Inc.
Colgate Palmolive Company
Dr. Reddys Laboratories Ltd.
GlaxoSmithKline, plc
Patterson Companies, Inc.
Pfizer Inc.
Prince Care Pharma Private Limited
3M
Other Prominent Players